United States
US 12,702,710 B2
Combination therapy of MDNA55 and a vascular endothelial growth factor a (VEGF-A)
US 12,702,710 B2 is a granted patent from the United States Patent and Trademark Office (USPTO), dated 2026-08-11. Applicant: Medicenna Therapeutics Inc. Its PDF downloads from this page without an account, up to 5 a day.
- Applicant
- Medicenna Therapeutics Inc.
- Inventors
- Fahar Merchant
- Publication date
- 2026-08-11
- Filing date
- 2023-04-11
- Document type
- B2 Granted patent
- Also written as
- US 12,702,710 B2 · US12702710 · 12702710
Abstract
Methods for treating a central nervous system (CNS) tumor in a subject, comprising administering to the subject MD-NA55 in combination with a vascular endothelial growth factor A (VEGF-A) inhibitor administered at a subtherapeutic level.
The opening of the abstract. The full text is in the PDF.
No account needed: 5 free downloads a day (5 left today). Batch downloads and Office Action citations need a free account.
Patent office website: United States Patent and Trademark Office (USPTO)
Look up another patent
Need many patents at once?
Paste a whole list of numbers. DownloadPatent finds the right version of each and packs the PDFs into one ZIP.
Sign up free